The Food and Drug Administration (FDA) is announcing a public workshop titled “Acute Ischemic Stroke Medical Devices Trials” scheduled for October 6, 2015.
The purpose of this workshop is to obtain public input and feedback on scientific, clinical, and regulatory considerations associated with acute ischemic stroke medical devices. Ideas generated during this workshop may facilitate further development of guidance regarding the content of premarket submissions for acute ischemic stroke emerging technologies and help to speed development and approval of future submissions. For details and registration, please see: http://www.fda.gov/
MedicalDevices/NewsEvents/ WorkshopsConferences/ ucm452337.htm.